Sort
8,912 grants matching “sars cov 2”
CEIRR: SARS-CoV-2 Research Activities
$1,014,000Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2023 · AI
SARS-CoV-2 Clinical Cohort Core
$1,013,890Dahlene Nicole Fusco · Tulane University Of Louisiana · U54 · FY2020 · CA
CO-CREATE-Ex: Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
$1,013,772Louise Chang Laurent · University Of California, San Diego · U01 · FY2023 · MD
Development of IN-003PI as passive immunization against human metapneumovirus infection
$1,013,468Jeff T Hutchins · Inhalon Biopharma, Inc. · R44 · FY2025 · AI
Systems Biology Approaches to Viral Pathogenesis and Immunity
$1,013,435Michael G Katze · Oregon Health & Science University · U54 · FY2009 · AI
HVTN 405/HPTN 1901 Characterizing SARS-CoV-2-specific immunity in convalescent individuals
$1,011,819Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2022 · AI
Determining the Fate of Transmembrane Proteins
$1,011,521Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Therapeutic and Diagnostic Antibodies Against SARS
$1,009,959Diversa Corporation · U01 · FY2004 · AI
Clinical Subjects and Biospecimen Core
$1,009,218Nirav Rati Bhakta · University Of California, San Francisco · U19 · FY2021 · AI
Epidemiology, transmission and immunology of COVID-19 in nursing home residents
$1,008,129David H Canaday · Case Western Reserve University · R01 · FY2020 · AI
SARS-CoV-2 Studies
$1,007,948Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
CoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
$1,007,764Myron S Cohen · Family Health International · UM1 · FY2023 · AI
Enhancing dengue virus genomic surveillance to uncover circulating genetic diversity
$1,007,000Nathan Dale Grubaugh · Yale University · DP2 · FY2025 · AI
Early Drivers of Humoral Immunity to SARS-CoV-2 Infections
$1,004,770Christopher L King · Case Western Reserve University · U01 · FY2023 · CA
Novel Cannabinoid Receptor Modulators
$1,004,709Malliga Iyer · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2021 · AA
AT191: An inhaled & precision RNA therapeutic with pan-variant SARS-CoV-2 efficacy
$1,004,473Ariel Weinberger · Autonomous Therapeutics, Inc. · R44 · FY2025 · AI
Evaluation of Smoke-Free Housing Policy Impacts on Tobacco Smoke Exposure and Health Outcomes
$1,004,207Lorna Thorpe · New York University School Of Medicine · R01 · FY2021 · CA
CTSA Administrative Supplement for Informatics Core: A novel AI/ML system to predict respiratory failure and ARDS in Covid-19 patients
$1,003,424Harry Shamoon · Albert Einstein College Of Medicine · UL1 · FY2020 · TR
University of Maryland Claude D. Pepper Older Americans Independence Center (OAIC)
$1,003,217Jay Steven Magaziner · University Of Maryland Baltimore · P30 · FY2021 · AG
Understanding antibody responses and defining correlates of protection for endemic and pandemic coronavirus strains
$1,001,583Viviana A Simon · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · AI
The economic and social impact of COVID-19 mitigation policies: A cross-country analysis of macro events
$1,000,672Dean R Lillard · Ohio State University · R01 · FY2021 · AG
MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESEARCH REPOSITORY (MID BRR) - SARS-CoV-2 RESEARCH
$1,000,590Timothy Stedman · American Type Culture Collection · N01 · FY2021 · AI
GMP production and GLP safety of bidirectionally targeted SARS-CoV-2 booster vaccine
$1,000,000Ellen Elizabeth Sparger · Tendel Therapies Inc. · R44 · FY2023 · AI
SARS-CoV-2 vaccines based on RBDs with engineered glycosylation sites
$1,000,000Michael David Alpert · Emmune, Inc · R44 · FY2025 · AI
Multidimensional antibody engineering to enhance the potency and breadth of a betacoronavirus medical countermeasure
$1,000,000Zachary A Bornholdt · Eitr Biologics, Inc. · R44 · FY2025 · AI